23032-21-5

Usage

Uses

Used in Pharmaceutical Industry:
D-LEUCINE METHYL ESTER HYDROCHLORIDE is used as a key component in the production of various drugs, contributing to the development of new medications and enhancing the therapeutic potential of existing ones.
Used in Research and Development:
D-LEUCINE METHYL ESTER HYDROCHLORIDE is used as a research tool for the exploration and understanding of peptide and protein synthesis, facilitating the discovery of novel therapeutic agents and advancing scientific knowledge in the field.
Used in Food and Beverage Industry:
D-LEUCINE METHYL ESTER HYDROCHLORIDE is used as a flavor enhancer, improving the taste and aroma of food and beverage products, thereby enhancing consumer appeal and satisfaction.
Used in Nutritional Supplements Production:
D-LEUCINE METHYL ESTER HYDROCHLORIDE is used in the formulation of nutritional supplements, providing essential amino acids to support health and well-being, and contributing to the overall effectiveness of these products.

InChI:InChI=1/C7H15NO2/c1-5(2)4-6(8)7(9)10-3/h5-6H,4,8H2,1-3H3/t6-/m1/s1

Upstream product

• 18869-43-7 DL-leucine methyl ester 
• 67-56-1 methanol 
• 303957-69-9 (2R)-4-acetyl-1,2-dihydro-5-hydroxy-2-(2-methylpropyl)-1-[(2E)-1-oxodec-2-enyl]-3H-pyrrol-3-one 
• 110098-02-7 2-(2-Aza-bicyclo[2.2.1]hept-5-en-2-yl)-4-methyl-pentanoic acid methyl ester; hydrochloride 
• 156174-28-6 methyl 2-(benzyloxycarbonylamino)-3-isopropylacrylate 
• 952524-02-6 (S)-1-benzoyl-2-(α-acetoxyethyl)benzimidazole 

Downstream Products

• 5845-54-5 Benzyloxycarbonyl-D-alanyl-D-leucin-methylester 
• 5845-56-7 N-(N-benzyloxycarbonyl-L-alanyl)-D-leucine methyl ester 
• 16679-76-8 Benzyloxycarbonyl-Phe-D-Leu-methylester 
• 118209-09-9 Z-Ala-Gly-D-Leu-OMe 
• 118209-08-8 Z-Val-Gly-D-Leu-OMe 
• 118209-07-7 Z-Leu-Gly-D-Leu-OMe 
• 115270-22-9 N-(benzyloxycarbonyl)-L-phenylalanyl-L-glycyl-D-leucine methyl ester 
• 53941-41-6 Z-Val-D-Leu-OMe 
• 7533-40-6 2-amino-4-methyl-1-pentanol 
• 28426-50-8 Z-Gly-D-LeuOMe 
• 83588-11-8 N-(tert-butyloxycarbonyl)-D-phenylalanyl-D-leucine methyl ester 
• 99597-71-4 methyl-(N-Boc-L-phenylalanine)-D-leucinate 
• 17665-02-0 L-leucyl-D-leucine 
• 184684-49-9 N-(N-benzyloxycarbonyl-L-leucyl)-D-leucine 

Relevant academic research and scientific papers

Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues

Optimization of the amino acid residue of a series of anthranilimide-based glycogen phosphorylase inhibitors is described leading to the identification of serine and threonine ether analogs. t-Butylthreonine analog 20 displayed potent in vitro inhibition of GPa, low potential for P450 inhibition, and excellent pharmacokinetic properties.

Enantioselective benzoylation of α-amino esters using (S)-1-benzoyl-2-(α-acetoxyethyl)benzimidazole, a chiral benzimidazolide

(Chemical Equation Presented) A new chiral benzimidazolide is developed as a nonenzymatic acylating agent for enantioselective benzoylation of racemic α-amino esters. The process is highly efficient, which exhibits uniformly high enantioselectivity for α-amino esters with or without aryl substituents under mild reaction conditions. The chiral benzimidazolide is inexpensive and is easily accessible.

The first low molecular weight antibiotic from lactic acid bacteria: Reutericyclin, a new tetramic acid

The first chemical proof is available to show that lactic acid bacteria, generally known for their limited metabolite spectrum, are able to produce antibiotics with a broad inhibitory spectrum. The new tetramic acid, reutericyclin (1), opens a new dimension in the discussion regarding the application of lactic acid bacteria in food preservation or for positively influencing the human intestinal microflora.